Liver Disease Clinical Trials in Houston

Showing 1-20 of 89 trials

Genetic Collection Protocol

NCT05272319

This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.

Liver Diseases

Arbor Research Collaborative for Health213 participantsStarted Apr 2022

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +10 more locations

Active Not RecruitingPhase 3< 1 mile

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

NCT05500222

This study will determine the effect of oral 80 mg resmetirom administered once daily on participants with well-compensated non-alcoholic steatohepatitis (NASH) cirrhosis by measuring the time to experiencing a Composite Clinical Outcome event.

NASHCirrhosis, Liver

Madrigal Pharmaceuticals, Inc.845 participantsStarted Aug 2022

Birmingham, Alabama, United States • Chandler, Arizona, United States • Peoria, Arizona, United States +113 more locations

Genetic Collection Protocol

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Liver Disease Trials in Other Cities

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease

An Observational Study of Patients With Chronic Liver Disease

Liver Cancer Prevention Randomized Control Trial

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

A Research Study on Etavopivat in Participants With and Without Liver Disease

A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK

A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Liver Cirrhosis Network Cohort Study

Other Conditions in Houston